Literature DB >> 8111944

Flumazenil as a diagnostic tool in the differential diagnosis of coma in a critically ill patient.

H Sprenger1, M D Sharpe, R S McLachlan.   

Abstract

The purpose of this report is to describe the use of flumazenil as a diagnostic aid in the differential diagnosis of coma in a patient with an inadvertent overdose of benzodiazepines. We report a patient with suspected septic encephalopathy whose level of consciousness markedly improved following flumazenil administration. Subsequent analysis revealed the presence of benzodiazepines and their metabolites in the blood and urine although the patient had not received benzodiazepines for over two weeks. The critically ill patient with multiorgan failure may have considerable derangement of benzodiazepine metabolism; therefore, if an obtunded patient's level of consciousness improves following flumazenil administration, benzodiazepine intoxication must be considered.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8111944     DOI: 10.1007/BF03009662

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  22 in total

1.  The diagnostic utility of flumazenil (a benzodiazepine antagonist) in coma of unknown etiology.

Authors:  K K Burkhart; K W Kulig
Journal:  Ann Emerg Med       Date:  1990-03       Impact factor: 5.721

2.  Amino acid alterations and encephalopathy in the sepsis syndrome.

Authors:  C L Sprung; F B Cerra; H R Freund; R M Schein; F N Konstantinides; E H Marcial; M Pena
Journal:  Crit Care Med       Date:  1991-06       Impact factor: 7.598

3.  Relationship of diazepam serum level to antianxiety effects.

Authors:  C L Bowden; J G Fisher
Journal:  J Clin Psychopharmacol       Date:  1982-04       Impact factor: 3.153

Review 4.  Flumazenil: a benzodiazepine antagonist.

Authors:  K A Karavokiros; G B Tsipis
Journal:  DICP       Date:  1990-10

5.  Drug interactions and clinical pharmacokinetics of flumazenil.

Authors:  U Klotz
Journal:  Eur J Anaesthesiol Suppl       Date:  1988

6.  Reversal of benzodiazepine sedation with the antagonist flumazenil.

Authors:  L D Sanders; S E Piggott; P A Isaac; R W Okell; B Roberts; M Rosen; J O Robinson
Journal:  Br J Anaesth       Date:  1991-04       Impact factor: 9.166

7.  Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans.

Authors:  G Bansky; P J Meier; E Riederer; H Walser; W H Ziegler; M Schmid
Journal:  Gastroenterology       Date:  1989-09       Impact factor: 22.682

8.  Use of flumazenil in the diagnosis and treatment of patients with coma of unknown etiology.

Authors:  E Winkler; S Almog; D Kriger; M S Tirosh; H Halkin; D Ezra
Journal:  Crit Care Med       Date:  1993-04       Impact factor: 7.598

9.  Recovery from fixed-dose midazolam-induced anaesthesia and antagonism with flumazenil for outpatient arthroscopy.

Authors:  W W Zuurmond; L van Leeuwen; J H Helmers
Journal:  Acta Anaesthesiol Scand       Date:  1989-02       Impact factor: 2.105

10.  "Endogenous" benzodiazepine activity in body fluids of patients with hepatic encephalopathy.

Authors:  K D Mullen; K M Szauter; K Kaminsky-Russ
Journal:  Lancet       Date:  1990-07-14       Impact factor: 79.321

View more
  1 in total

Review 1.  A risk-benefit assessment of flumazenil in the management of benzodiazepine overdose.

Authors:  A A Weinbroum; R Flaishon; P Sorkine; O Szold; V Rudick
Journal:  Drug Saf       Date:  1997-09       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.